NIDDK: Dieting & Gallstones Stokes 2021 review Yang 1992
ShahidMGaoJZhouYLiuGAliTDengYet al
Semaglutide and tirzepatide are taken once a week
9 The consensus statement from the American Association of Clinical Endocrinologists supports the use of GLP-1 RAs as first-line therapy in managing hyperglycaemia in T2D patients with established (or at high risk of) atherosclerotic CVD, as well as in those with chronic kidney disease or a history of stroke or transient ischaemic attack, while recommending the administration of sodiumglucose cotransporter 2 inhibitors to HF patients
These impacts are especially noticeable in the first four to eight weeks of a patients GLP-1 weight loss journey, leading to issues like constipation, nausea, bloating, vomiting, and other gastrointestinal discomforts
Our team members work closely across departments, sharing knowledge and expertise to achieve common goals